Literature DB >> 17060323

Identification of nuclear import mechanisms for the neuronal Cdk5 activator.

Xinrong Fu1, Yuk-Kwan Choi, Dianbo Qu, Yan Yu, Nam Sang Cheung, Robert Z Qi.   

Abstract

The activation of Cdk5 by p35 plays a pivotal role in a multitude of nervous system activities ranging from neuronal differentiation to degeneration. A fraction of Cdk5 and p35 localizes in the nucleus where Cdk5-p35 exerts its functions via protein phosphorylation, and p35 displays a dynamic localization between the cytoplasm and the nucleus. Here, we examined the nuclear import properties of p35. In nuclear import assays, p35 was actively transported into the nuclei of digitonin-permeabilized HeLa cells and cortical neurons by cytoplasmic carrier-mediated mechanisms. Importin-beta, importin-5, and importin-7 were identified to import p35 into the nuclei via a direct interaction with it. An N-terminal region of p35 was defined to interact with the above importins, serving as a nuclear localization signal. Finally, we show that the nuclear localization of p35 does not require the association of Cdk5. Furthermore, Cdk5 and importin-beta/5/7 are mutually exclusive in binding to p35. These results suggest that p35 employs pathways distinct from that used by Cdk5 for transport to the nucleus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060323     DOI: 10.1074/jbc.M512663200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.

Authors:  Anja Büchner; Petranka Krumova; Sundar Ganesan; Mathias Bähr; Katrin Eckermann; Jochen H Weishaupt
Journal:  Neuromolecular Med       Date:  2014-11-13       Impact factor: 3.843

2.  A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.

Authors:  Ya-Li Zheng; Niranjana D Amin; Ya-Fang Hu; Parvathi Rudrabhatla; Varsha Shukla; Jyotshnabala Kanungo; Sashi Kesavapany; Philip Grant; Wayne Albers; Harish C Pant
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

3.  The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein.

Authors:  Lisheng He; Zhaojun Zhang; Yan Yu; Sohail Ahmed; Nam Sang Cheung; Robert Z Qi
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

4.  Interaction of CDK5RAP2 with EB1 to track growing microtubule tips and to regulate microtubule dynamics.

Authors:  Ka-Wing Fong; Shiu-Yeung Hau; Yik-Shing Kho; Yue Jia; Lisheng He; Robert Z Qi
Journal:  Mol Biol Cell       Date:  2009-06-24       Impact factor: 4.138

5.  Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.

Authors:  Raphaël Rouget; Gyanesh Sharma; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

6.  Cdk5 controls IL-2 gene expression via repression of the mSin3a-HDAC complex.

Authors:  Eric Lam; Tej K Pareek; John J Letterio
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex.

Authors:  Jie Zhang; Huifang Li; Odessa Yabut; Haley Fitzpatrick; Gabriella D'Arcangelo; Karl Herrup
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

8.  Cdk5 nuclear localization is p27-dependent in nerve cells: implications for cell cycle suppression and caspase-3 activation.

Authors:  Jie Zhang; Huifang Li; Karl Herrup
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

9.  Beta-like importins mediate the nuclear translocation of mitogen-activated protein kinases.

Authors:  Eldar Zehorai; Rony Seger
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

10.  p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.

Authors:  Lingyan Zhang; Wen Liu; Karen K Szumlinski; John Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.